Ambalal Sarabhai Enterprises Limited (AMBALALSA.BO)
INR 61.25
(-0.52%)
INR 61.25
(-0.52%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 170.57 Million INR | -69.21% |
| 2022 | 213.29 Million INR | -53.84% |
| 2021 | 521.33 Million INR | 95.2% |
| 2020 | 227.8 Million INR | 11.1% |
| 2019 | 224.87 Million INR | 46.81% |
| 2018 | 113.56 Million INR | 1575.11% |
| 2017 | 133.02 Million INR | 53.18% |
| 2016 | -48.57 Million INR | 82.15% |
| 2015 | -106.66 Million INR | -353.07% |
| 2014 | 86.56 Million INR | 83.86% |
| 2013 | -56.18 Million INR | -539.58% |
| 2012 | 43.5 Million INR | 0.0% |
| 2009 | -169.96 Million INR | 85.09% |
| 2008 | -1.13 Billion INR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 8.34 Million INR | -70.17% |
| 2023 Q2 | 38.65 Million INR | 701.6% |
| 2023 Q3 | 25.29 Million INR | -34.56% |
| 2023 Q4 | 57.28 Million INR | 126.48% |
| 2023 FY | - INR | -69.21% |
| 2023 Q1 | -6.42 Million INR | -106.87% |
| 2022 Q2 | 31.15 Million INR | -9.26% |
| 2022 FY | - INR | -53.84% |
| 2022 Q1 | 34.33 Million INR | 118.1% |
| 2022 Q3 | 46.27 Million INR | 48.51% |
| 2022 Q4 | 93.47 Million INR | 102.01% |
| 2021 Q4 | -189.75 Million INR | -387.79% |
| 2021 Q3 | 65.93 Million INR | -44.88% |
| 2021 FY | - INR | 95.2% |
| 2021 Q2 | 119.62 Million INR | -22.9% |
| 2021 Q1 | 155.14 Million INR | -8.62% |
| 2020 Q4 | 169.77 Million INR | 258.2% |
| 2020 FY | - INR | 11.1% |
| 2020 Q3 | 47.39 Million INR | -63.95% |
| 2020 Q2 | 131.46 Million INR | 369.31% |
| 2020 Q1 | 28.01 Million INR | -82.02% |
| 2019 Q1 | 19.89 Million INR | -61.57% |
| 2019 FY | - INR | 46.81% |
| 2019 Q3 | 14.69 Million INR | 0.13% |
| 2019 Q4 | 155.77 Million INR | 959.98% |
| 2019 Q2 | 14.67 Million INR | -26.22% |
| 2018 Q3 | 44.38 Million INR | 84.04% |
| 2018 Q2 | 24.11 Million INR | 24.4% |
| 2018 Q1 | 19.38 Million INR | 158.98% |
| 2018 Q4 | 51.76 Million INR | 16.63% |
| 2018 FY | - INR | 1575.11% |
| 2017 FY | - INR | 53.18% |
| 2017 Q4 | -32.86 Million INR | -176.82% |
| 2017 Q3 | 42.78 Million INR | 374.33% |
| 2017 Q2 | -15.59 Million INR | -311.5% |
| 2017 Q1 | -3.79 Million INR | 0.0% |
| 2016 FY | - INR | 82.15% |
| 2015 FY | - INR | -353.07% |
| 2014 FY | - INR | 83.86% |
| 2013 FY | - INR | -539.58% |
| 2012 FY | - INR | 0.0% |
| 2009 FY | - INR | 85.09% |
| 2008 FY | - INR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Hindustan Bio Sciences Limited | 638.75 Thousand INR | -26603.864% |
| KIMIA BIOSCIENCES LIMITED | 11.58 Million INR | -1372.479% |
| SHELTER PHARMA LIMITED | 89.01 Million INR | -91.632% |
| Vasundhara Rasayans Limited | 84.22 Million INR | -102.517% |
| Sunil Healthcare Limited | 93.07 Million INR | -83.255% |
| Chemo Pharma Laboratories Limited | 16.51 Million INR | -932.643% |
| MedPlus Health Services Limited | 3.94 Billion INR | 95.672% |
| Bharat Immunologicals & Biologicals Corporation Limited | -151.05 Million INR | 212.922% |
| Patidar Buildcon Limited | -5.52 Million INR | 3186.717% |
| Roopa Industries Limited | 55.7 Million INR | -206.228% |
| Smruthi Organics Limited | 120.31 Million INR | -41.775% |
| Trident Lifeline Limited | 102.69 Million INR | -66.099% |
| PANJON LTD. | 4.08 Million INR | -4071.484% |
| Pharmaids Pharmaceuticals Limited | -123.28 Million INR | 238.359% |
| Gujarat Terce Laboratories Limited | 15.87 Million INR | -974.334% |
| TIAAN CONSUMER LIMITED | -19.05 Million INR | 995.297% |
| Anuh Pharma Limited | 878.5 Million INR | 80.584% |
| Crestchem Limited | 30.33 Million INR | -462.307% |
| Emmessar Biotech & Nutrition Limited | -10.81 Million INR | 1676.742% |
| Sandu Pharmaceuticals Limited | 27.19 Million INR | -527.264% |
| Tyche Industries Limited | 128.2 Million INR | -33.044% |
| Fredun Pharmaceuticals Limited | 388.97 Million INR | 56.149% |
| Trimurthi Limited | -2.47 Million INR | 6982.038% |
| Shukra Pharmaceuticals Limited | 216.59 Million INR | 21.248% |
| Norris Medicines Limited | -1.78 Million INR | 9660.434% |
| Zenlabs Ethica Limited | 27.09 Million INR | -529.51% |
| Vikram Thermo (India) Limited | 386.92 Million INR | 55.916% |
| ANG Lifesciences India Limited | 90.66 Million INR | -88.141% |
| Parmax Pharma Limited | 22.93 Million INR | -643.638% |
| Veerhealth Care Limited | 15.99 Million INR | -966.408% |
| Deccan Health Care Limited | 37.5 Million INR | -354.786% |
| SUDARSHAN PHARMA INDUSTRIES LI | 254.17 Million INR | 32.891% |
| Makers Laboratories Limited | 25.81 Million INR | -560.824% |
| Lactose (India) Limited | 201.22 Million INR | 15.232% |
| OXYGENTA PHARMACEUTICAL LIMITE | -96.17 Million INR | 277.363% |
| Zenith Healthcare Limited | 4.98 Million INR | -3319.647% |
| Sanjivani Paranteral Limited. | 87.58 Million INR | -94.756% |
| Bacil Pharma Limited | -569.32 Thousand INR | 30060.655% |
| PRAVEG LIMITED | 321.43 Million INR | 46.934% |
| Denis Chem Lab Limited | 224.84 Million INR | 24.139% |
| Kwality Pharmaceuticals Limited | 610.44 Million INR | 72.058% |
| Jenburkt Pharmaceuticals Limited | 377.86 Million INR | 54.859% |
| Colinz Laboratories Limited | 5.42 Million INR | -3042.447% |
| Godavari Drugs Limited | 134.62 Million INR | -26.702% |
| SHAMROCK INDUSTRIAL CO.LTD. | -406 Thousand INR | 42112.808% |
| Zenotech Laboratories Limited | 172.64 Million INR | 1.201% |
| Panchsheel Organics Limited | 189.36 Million INR | 9.925% |
| Shree Ganesh Remedies Limited | 448.77 Million INR | 61.992% |
| Vivanza Biosciences Limited | 11.2 Million INR | -1422.421% |
| Phaarmasia Limited | -1.58 Million INR | 10882.048% |
| Sastasundar Ventures Limited | -203.51 Million INR | 183.814% |
| Medi-Caps Limited | 4.77 Million INR | -3475.183% |
| DECIPHER LABS LIMITED | -2.72 Million INR | 6371.029% |
| Gujarat Themis Biosyn Limited | 830.99 Million INR | 79.474% |
| Mercury Laboratories Limited | 101.18 Million INR | -68.569% |
| Gennex Laboratories Limited | 219.35 Million INR | 22.24% |
| BDH Industries Limited | 124.27 Million INR | -37.256% |
| Coral Laboratories Limited | 227.07 Million INR | 24.883% |
| Concord Drugs Limited | 40.52 Million INR | -320.958% |
| Bharat Parenterals Limited | 265.74 Million INR | 35.813% |
| Beryl Drugs Limited | 26.63 Million INR | -540.309% |
| Vista Pharmaceuticals Limited | -32.37 Million INR | 626.798% |
| Evoq Remedies Limited | 6.18 Million INR | -2656.508% |
| Add-Shop E-Retail Limited | 82.61 Million INR | -106.466% |
| Transchem Limited | 56.61 Million INR | -201.305% |
| Ishita Drugs and Industries Limited | 11.88 Million INR | -1334.825% |
| Parnax Lab Limited | 243.59 Million INR | 29.978% |
| Source Natural Foods and Herbal Supplements Limited | 44.8 Million INR | -280.707% |
| Kerala Ayurveda Limited | 70.78 Million INR | -140.965% |
| Cian Healthcare Limited | 122.56 Million INR | -39.166% |
| Trinity League India Limited | -26.25 Million INR | 749.724% |
| Syschem (India) Limited | 70.4 Million INR | -142.286% |
| KOBO BIOTECH LIMITED | -8.57 Million INR | 2089.642% |
| Natural Capsules Limited | 219.9 Million INR | 22.432% |
| Auro Laboratories Limited | 121.73 Million INR | -40.116% |